| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | SELE SYT3 PCDHGA2 ITSN1 CAPSL CAPS ACTN1 TENM2 CEMIP2 HPCA SLC25A12 HMCN1 NRXN1 OTOF HPCAL1 LRP2 TESC EML1 PADI2 | 2.13e-06 | 749 | 145 | 19 | GO:0005509 |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 3.71e-06 | 5 | 145 | 3 | GO:0097109 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 9.50e-06 | 19 | 145 | 4 | GO:0004890 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 1.76e-05 | 22 | 145 | 4 | GO:0016917 | |
| GeneOntologyMolecularFunction | palmitoleoyltransferase activity | 5.24e-05 | 2 | 145 | 2 | GO:1990698 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 5.82e-05 | 57 | 145 | 5 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 7.46e-05 | 60 | 145 | 5 | GO:0099529 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 8.99e-05 | 100 | 145 | 6 | GO:0030594 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 1.10e-04 | 65 | 145 | 5 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 1.10e-04 | 65 | 145 | 5 | GO:0022824 | |
| GeneOntologyMolecularFunction | ribonucleoside binding | 1.56e-04 | 3 | 145 | 2 | GO:0032549 | |
| GeneOntologyMolecularFunction | Arp2/3 complex binding | 1.96e-04 | 16 | 145 | 3 | GO:0071933 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 2.16e-04 | 75 | 145 | 5 | GO:0098960 | |
| GeneOntologyMolecularFunction | hexosaminidase activity | 2.37e-04 | 17 | 145 | 3 | GO:0015929 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 2.45e-04 | 77 | 145 | 5 | GO:0005230 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 2.83e-04 | 18 | 145 | 3 | GO:0022851 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GABRB1 SELE GABRD GABRG2 GABRG3 SEMA4D ERBB3 FLT3 OR5I1 NTRK1 CCR9 INSRR OR1A2 GRIA4 NRXN3 NRXN1 NRXN2 GPR158 PAX8 CXCR4 OR6C4 SORL1 | 3.05e-04 | 1353 | 145 | 22 | GO:0004888 |
| GeneOntologyMolecularFunction | DNA/RNA hybrid binding | 5.16e-04 | 5 | 145 | 2 | GO:0071667 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 6.72e-04 | 145 | 145 | 6 | GO:0004713 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 6.79e-04 | 24 | 145 | 3 | GO:0099507 | |
| GeneOntologyMolecularFunction | neuregulin binding | 7.71e-04 | 6 | 145 | 2 | GO:0038132 | |
| GeneOntologyMolecularFunction | chemorepellent activity | 1.19e-03 | 29 | 145 | 3 | GO:0045499 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 1.28e-03 | 65 | 145 | 4 | GO:0004714 | |
| GeneOntologyMolecularFunction | DNA-directed 5'-3' RNA polymerase activity | 1.32e-03 | 30 | 145 | 3 | GO:0003899 | |
| GeneOntologyMolecularFunction | 5'-3' RNA polymerase activity | 1.59e-03 | 32 | 145 | 3 | GO:0034062 | |
| GeneOntologyMolecularFunction | RNA polymerase activity | 1.59e-03 | 32 | 145 | 3 | GO:0097747 | |
| GeneOntologyMolecularFunction | kinase regulator activity | 1.77e-03 | 305 | 145 | 8 | GO:0019207 | |
| GeneOntologyMolecularFunction | hyalurononglucosaminidase activity | 1.82e-03 | 9 | 145 | 2 | GO:0004415 | |
| GeneOntologyBiologicalProcess | cardiac ventricle development | 1.57e-06 | 161 | 140 | 9 | GO:0003231 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 1.48e-05 | 212 | 140 | 9 | GO:0003205 | |
| GeneOntologyBiologicalProcess | hemopoiesis | DPP4 FLT3 CEBPD NTRK1 CCR9 NAGLU ACTN1 MED1 ITGAM SOX13 OPA1 RHAG CHUK TXK NFATC1 DROSHA PTPRQ RBPJ TESC EML1 PREX1 HSP90AA1 | 2.58e-05 | 1223 | 140 | 22 | GO:0030097 |
| GeneOntologyBiologicalProcess | leukocyte differentiation | DPP4 FLT3 NTRK1 CCR9 NAGLU MED1 ITGAM SOX13 OPA1 CHUK TXK NFATC1 DROSHA RBPJ TESC PREX1 HSP90AA1 | 2.59e-05 | 789 | 140 | 17 | GO:0002521 |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | DPP4 FLT3 NTRK1 CCR9 NAGLU MED1 ITGAM SOX13 OPA1 TXK NFATC1 DROSHA RBPJ PREX1 HSP90AA1 | 3.07e-05 | 640 | 140 | 15 | GO:1903131 |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | APAF1 ETV4 MED1 ITGAX GRHL2 OPA1 NFATC1 PAX8 CXCR4 RBPJ LRP2 GRHL3 | 3.10e-05 | 421 | 140 | 12 | GO:0060562 |
| GeneOntologyBiologicalProcess | ventricular septum development | 3.65e-05 | 91 | 140 | 6 | GO:0003281 | |
| GeneOntologyBiologicalProcess | synapse organization | GABRG2 GABRG3 SEMA4D NTRK1 ITSN1 ACTN1 CSMD2 ITGAM OPA1 NRXN3 NRXN1 NRXN2 GPR158 CTTN WASF1 | 6.64e-05 | 685 | 140 | 15 | GO:0050808 |
| GeneOntologyBiologicalProcess | adult behavior | 7.55e-05 | 203 | 140 | 8 | GO:0030534 | |
| GeneOntologyBiologicalProcess | postsynaptic density assembly | 8.05e-05 | 34 | 140 | 4 | GO:0097107 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | APAF1 NAGLU ETV4 MED1 ITGAX GRHL2 OPA1 CHUK NFATC1 PAX8 CXCR4 RBPJ LRP2 GRHL3 | 8.37e-05 | 619 | 140 | 14 | GO:0002009 |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid signaling pathway | 9.04e-05 | 35 | 140 | 4 | GO:0007214 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 1.04e-04 | 337 | 140 | 10 | GO:0006898 | |
| GeneOntologyBiologicalProcess | cell junction organization | GABRG2 GABRG3 SEMA4D NTRK1 ITSN1 ACTN1 CSMD2 ITGAM HNF4A GRHL2 ITGB4 OPA1 NRXN3 NRXN1 NRXN2 GPR158 CTTN WASF1 | 1.08e-04 | 974 | 140 | 18 | GO:0034330 |
| GeneOntologyBiologicalProcess | axon guidance | 1.46e-04 | 285 | 140 | 9 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 1.50e-04 | 286 | 140 | 9 | GO:0097485 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 1.61e-04 | 16 | 140 | 3 | GO:0007158 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | APAF1 NAGLU ETV4 EXT2 MED1 ITGAX GRHL2 OPA1 CHUK NFATC1 PAX8 CXCR4 RBPJ LRP2 GRHL3 | 1.80e-04 | 750 | 140 | 15 | GO:0048729 |
| GeneOntologyBiologicalProcess | postsynaptic specialization assembly | 2.24e-04 | 44 | 140 | 4 | GO:0098698 | |
| GeneOntologyBiologicalProcess | excitatory synapse assembly | 2.66e-04 | 46 | 140 | 4 | GO:1904861 | |
| GeneOntologyBiologicalProcess | B-1a B cell differentiation | 2.72e-04 | 4 | 140 | 2 | GO:0002337 | |
| GeneOntologyBiologicalProcess | neuroligin clustering involved in postsynaptic membrane assembly | 2.72e-04 | 4 | 140 | 2 | GO:0097118 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | ERBB3 FLT3 CYP3A4 ETV4 MED1 HNF4A ITGAX CREBBP OPA1 HNRNPCL3 CHUK TXK POLR3B NRXN1 NFATC1 DROSHA RBPJ TESC GRHL3 PADI2 HSP90AA1 SORL1 | 2.96e-04 | 1446 | 140 | 22 | GO:0010628 |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | DPP4 FLT3 NTRK1 CCR9 SOX13 OPA1 TXK NFATC1 DROSHA RBPJ PREX1 HSP90AA1 | 3.05e-04 | 537 | 140 | 12 | GO:0030098 |
| GeneOntologyBiologicalProcess | cardiac septum development | 3.09e-04 | 134 | 140 | 6 | GO:0003279 | |
| GeneOntologyBiologicalProcess | cardiac ventricle morphogenesis | 3.34e-04 | 88 | 140 | 5 | GO:0003208 | |
| GeneOntologyBiologicalProcess | inner ear development | 3.40e-04 | 253 | 140 | 8 | GO:0048839 | |
| GeneOntologyBiologicalProcess | morphogenesis of an endothelium | 3.72e-04 | 21 | 140 | 3 | GO:0003159 | |
| GeneOntologyBiologicalProcess | endothelial tube morphogenesis | 3.72e-04 | 21 | 140 | 3 | GO:0061154 | |
| GeneOntologyBiologicalProcess | cell adhesion mediated by integrin | 3.91e-04 | 91 | 140 | 5 | GO:0033627 | |
| GeneOntologyBiologicalProcess | protein retention in Golgi apparatus | 4.51e-04 | 5 | 140 | 2 | GO:0045053 | |
| GeneOntologyBiologicalProcess | gephyrin clustering involved in postsynaptic density assembly | 4.51e-04 | 5 | 140 | 2 | GO:0097116 | |
| GeneOntologyCellularComponent | synaptic membrane | GABRB1 GABRD GABRG2 GABRG3 ERBB3 SYT3 ITSN1 GRIA4 CSMD2 ITGB4 TENM2 NRXN3 NRXN1 NRXN2 OTOF GPR158 CLTC KCNMA1 | 1.01e-07 | 583 | 143 | 18 | GO:0097060 |
| GeneOntologyCellularComponent | receptor complex | GABRB1 GABRD GABRG2 GABRG3 SEMA4D ERBB3 FLT3 NTRK1 INSRR PORCN GRIA4 ITGAM ITGAX ITGB4 CHUK PTPRQ LRP2 | 4.98e-07 | 581 | 143 | 17 | GO:0043235 |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 1.07e-06 | 78 | 143 | 7 | GO:0048787 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | 7.51e-06 | 19 | 143 | 4 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 1.15e-05 | 21 | 143 | 4 | GO:1902710 | |
| GeneOntologyCellularComponent | glutamatergic synapse | GABRD GABRG2 CNNM2 ITSN1 PORCN GRIA4 ACTN1 CSMD2 ITGB4 TENM2 HPCA NRXN3 NRXN1 NRXN2 DROSHA CLTC KCNMA1 CTTN | 1.22e-05 | 817 | 143 | 18 | GO:0098978 |
| GeneOntologyCellularComponent | clathrin-coated pit | 1.83e-05 | 80 | 143 | 6 | GO:0005905 | |
| GeneOntologyCellularComponent | presynaptic membrane | GABRB1 ITSN1 GRIA4 NRXN3 NRXN1 NRXN2 OTOF GPR158 CLTC KCNMA1 | 2.16e-05 | 277 | 143 | 10 | GO:0042734 |
| GeneOntologyCellularComponent | axon | GABRD GABRG2 NTRK1 ITSN1 INSRR GRIA4 TENM2 OPA1 MADD HPCA NRXN1 CXCR4 KCNMA1 LRP2 SLC2A13 CTTN PREX1 HSP90AA1 | 3.85e-05 | 891 | 143 | 18 | GO:0030424 |
| GeneOntologyCellularComponent | presynaptic active zone | 5.33e-05 | 141 | 143 | 7 | GO:0048786 | |
| GeneOntologyCellularComponent | postsynapse | GABRB1 GABRD GABRG2 GABRG3 ERBB3 SYT3 ITSN1 GRIA4 ACTN1 CSMD2 ITGB4 TENM2 HPCA GPR158 DROSHA CLTC KCNMA1 CTTN WASF1 | 6.72e-05 | 1018 | 143 | 19 | GO:0098794 |
| GeneOntologyCellularComponent | postsynaptic membrane | GABRB1 GABRD GABRG2 GABRG3 ERBB3 GRIA4 CSMD2 ITGB4 TENM2 GPR158 KCNMA1 | 1.11e-04 | 405 | 143 | 11 | GO:0045211 |
| GeneOntologyCellularComponent | GABA-ergic synapse | 1.38e-04 | 164 | 143 | 7 | GO:0098982 | |
| GeneOntologyCellularComponent | cell leading edge | GABRG2 GABRG3 DPP4 ITSN1 ACTN1 ITGB4 JMY HPCA CXCR4 TESC CTTN WASF1 | 1.72e-04 | 500 | 143 | 12 | GO:0031252 |
| GeneOntologyCellularComponent | distal axon | ITSN1 GRIA4 TENM2 NRXN1 CXCR4 KCNMA1 LRP2 SLC2A13 CTTN PREX1 HSP90AA1 | 2.06e-04 | 435 | 143 | 11 | GO:0150034 |
| GeneOntologyCellularComponent | dendrite | GABRB1 GABRD GABRG2 GABRG3 NTRK1 ITSN1 GRIA4 ACTN1 TENM2 OPA1 HPCA KCNMA1 LRP2 CTTN PREX1 HSP90AA1 | 2.65e-04 | 858 | 143 | 16 | GO:0030425 |
| GeneOntologyCellularComponent | somatodendritic compartment | GABRB1 GABRD GABRG2 GABRG3 PDE1A NTRK1 ITSN1 GRIA4 ACTN1 TENM2 OPA1 GIP HPCA NRXN1 KCNMA1 LRP2 CTTN PREX1 HSP90AA1 SORL1 | 2.67e-04 | 1228 | 143 | 20 | GO:0036477 |
| GeneOntologyCellularComponent | dendritic tree | GABRB1 GABRD GABRG2 GABRG3 NTRK1 ITSN1 GRIA4 ACTN1 TENM2 OPA1 HPCA KCNMA1 LRP2 CTTN PREX1 HSP90AA1 | 2.72e-04 | 860 | 143 | 16 | GO:0097447 |
| GeneOntologyCellularComponent | growth cone | 2.90e-04 | 245 | 143 | 8 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 3.59e-04 | 253 | 143 | 8 | GO:0030427 | |
| GeneOntologyCellularComponent | chloride channel complex | 6.26e-04 | 57 | 143 | 4 | GO:0034707 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 7.14e-04 | 59 | 143 | 4 | GO:0098636 | |
| GeneOntologyCellularComponent | nuclear DNA-directed RNA polymerase complex | 1.08e-03 | 113 | 143 | 5 | GO:0055029 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.20e-03 | 378 | 143 | 9 | GO:0034702 | |
| GeneOntologyCellularComponent | DNA-directed RNA polymerase complex | 1.22e-03 | 116 | 143 | 5 | GO:0000428 | |
| GeneOntologyCellularComponent | endocytic vesicle | 1.33e-03 | 384 | 143 | 9 | GO:0030139 | |
| GeneOntologyCellularComponent | integrin complex | 1.34e-03 | 32 | 143 | 3 | GO:0008305 | |
| GeneOntologyCellularComponent | RNA polymerase complex | 1.37e-03 | 119 | 143 | 5 | GO:0030880 | |
| GeneOntologyCellularComponent | dense core granule membrane | 2.02e-03 | 10 | 143 | 2 | GO:0032127 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 2.19e-03 | 335 | 143 | 8 | GO:0061695 | |
| GeneOntologyCellularComponent | late endosome | 2.77e-03 | 348 | 143 | 8 | GO:0005770 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 2.87e-03 | 350 | 143 | 8 | GO:0098802 | |
| GeneOntologyCellularComponent | basal plasma membrane | 3.07e-03 | 354 | 143 | 8 | GO:0009925 | |
| GeneOntologyCellularComponent | axonal growth cone | 3.61e-03 | 45 | 143 | 3 | GO:0044295 | |
| Domain | Syndecan | 1.44e-05 | 7 | 141 | 3 | PF01034 | |
| Domain | Syndecan/Neurexin_dom | 1.44e-05 | 7 | 141 | 3 | IPR027789 | |
| Domain | GABAA/Glycine_rcpt | 2.47e-05 | 23 | 141 | 4 | IPR006028 | |
| Domain | EFh | 2.69e-05 | 158 | 141 | 8 | SM00054 | |
| Domain | VWFA | 3.64e-05 | 82 | 141 | 6 | PS50234 | |
| Domain | VWA | 4.17e-05 | 84 | 141 | 6 | SM00327 | |
| Domain | Tyr_kinase_cat_dom | 5.42e-05 | 88 | 141 | 6 | IPR020635 | |
| Domain | TyrKc | 5.42e-05 | 88 | 141 | 6 | SM00219 | |
| Domain | EF_Hand_1_Ca_BS | 5.56e-05 | 175 | 141 | 8 | IPR018247 | |
| Domain | PROTEIN_KINASE_TYR | 9.36e-05 | 97 | 141 | 6 | PS00109 | |
| Domain | Tyr_kinase_AS | 9.36e-05 | 97 | 141 | 6 | IPR008266 | |
| Domain | VWF_A | 1.05e-04 | 99 | 141 | 6 | IPR002035 | |
| Domain | Neurexin-like | 1.44e-04 | 14 | 141 | 3 | IPR003585 | |
| Domain | 4.1m | 1.44e-04 | 14 | 141 | 3 | SM00294 | |
| Domain | EF-hand_1 | 1.57e-04 | 152 | 141 | 7 | PF00036 | |
| Domain | EF_HAND_1 | 1.62e-04 | 204 | 141 | 8 | PS00018 | |
| Domain | EGF-like_CS | 1.67e-04 | 261 | 141 | 9 | IPR013032 | |
| Domain | - | 1.69e-04 | 3 | 141 | 2 | 2.40.270.10 | |
| Domain | RNA_pol_RPB2_OB-fold | 1.69e-04 | 3 | 141 | 2 | IPR014724 | |
| Domain | RNA_pol_bsu_CS | 1.69e-04 | 3 | 141 | 2 | IPR007121 | |
| Domain | DNA-dir_RNA_pol_su2_6 | 1.69e-04 | 3 | 141 | 2 | IPR007120 | |
| Domain | RNA_pol_Rpb2_7 | 1.69e-04 | 3 | 141 | 2 | PF04560 | |
| Domain | RNA_pol_Rpb2_2 | 1.69e-04 | 3 | 141 | 2 | PF04561 | |
| Domain | RNA_pol_Rpb2_5 | 1.69e-04 | 3 | 141 | 2 | PF04567 | |
| Domain | RNA_pol_Rpb2_1 | 1.69e-04 | 3 | 141 | 2 | PF04563 | |
| Domain | RNA_pol_Rpb2_3 | 1.69e-04 | 3 | 141 | 2 | PF04565 | |
| Domain | RNA_pol_Rpb2_5 | 1.69e-04 | 3 | 141 | 2 | IPR007647 | |
| Domain | RNA_pol_Rpb2_3 | 1.69e-04 | 3 | 141 | 2 | IPR007645 | |
| Domain | RNA_pol_bsu_protrusion | 1.69e-04 | 3 | 141 | 2 | IPR007644 | |
| Domain | RNA_pol_Rpb2_2 | 1.69e-04 | 3 | 141 | 2 | IPR007642 | |
| Domain | RNA_pol_Rpb2_7 | 1.69e-04 | 3 | 141 | 2 | IPR007641 | |
| Domain | GABBAg_rcpt | 1.69e-04 | 3 | 141 | 2 | IPR005437 | |
| Domain | - | 1.69e-04 | 3 | 141 | 2 | 2.40.50.150 | |
| Domain | RNA_POL_BETA | 1.69e-04 | 3 | 141 | 2 | PS01166 | |
| Domain | - | 1.69e-04 | 3 | 141 | 2 | 3.90.1110.10 | |
| Domain | DNA-dir_RNA_pol_su2 | 1.69e-04 | 3 | 141 | 2 | IPR015712 | |
| Domain | RNA_pol_Rpb2_6 | 1.69e-04 | 3 | 141 | 2 | PF00562 | |
| Domain | EGF_2 | 1.87e-04 | 265 | 141 | 9 | PS01186 | |
| Domain | G8_domain | 3.36e-04 | 4 | 141 | 2 | IPR019316 | |
| Domain | G8 | 3.36e-04 | 4 | 141 | 2 | PS51484 | |
| Domain | G8 | 3.36e-04 | 4 | 141 | 2 | SM01225 | |
| Domain | G8 | 3.36e-04 | 4 | 141 | 2 | PF10162 | |
| Domain | Neurotransmitter_ion_chnl_CS | 3.65e-04 | 45 | 141 | 4 | IPR018000 | |
| Domain | EF_HAND_2 | 3.75e-04 | 231 | 141 | 8 | PS50222 | |
| Domain | EF_hand_dom | 3.86e-04 | 232 | 141 | 8 | IPR002048 | |
| Domain | EGF | 3.90e-04 | 126 | 141 | 6 | PF00008 | |
| Domain | Neur_chan_memb | 3.97e-04 | 46 | 141 | 4 | PF02932 | |
| Domain | PSI | 3.97e-04 | 46 | 141 | 4 | SM00423 | |
| Domain | EGF | 4.20e-04 | 235 | 141 | 8 | SM00181 | |
| Domain | EGF_3 | 4.20e-04 | 235 | 141 | 8 | PS50026 | |
| Domain | Neurotrans-gated_channel_TM | 4.32e-04 | 47 | 141 | 4 | IPR006029 | |
| Domain | - | 4.32e-04 | 47 | 141 | 4 | 2.70.170.10 | |
| Domain | Neur_chan_LBD | 4.32e-04 | 47 | 141 | 4 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 4.32e-04 | 47 | 141 | 4 | PS00236 | |
| Domain | Neur_channel | 4.32e-04 | 47 | 141 | 4 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 4.32e-04 | 47 | 141 | 4 | IPR006202 | |
| Domain | Pkinase_Tyr | 4.42e-04 | 129 | 141 | 6 | PF07714 | |
| Domain | FG_GAP | 5.84e-04 | 22 | 141 | 3 | PS51470 | |
| Domain | EGF-like_dom | 6.15e-04 | 249 | 141 | 8 | IPR000742 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 6.32e-04 | 138 | 141 | 6 | IPR001245 | |
| Domain | EGF_1 | 7.19e-04 | 255 | 141 | 8 | PS00022 | |
| Domain | FG-GAP | 7.59e-04 | 24 | 141 | 3 | PF01839 | |
| Domain | FG-GAP | 7.59e-04 | 24 | 141 | 3 | IPR013517 | |
| Domain | CP2 | 8.32e-04 | 6 | 141 | 2 | PF04516 | |
| Domain | CP2 | 8.32e-04 | 6 | 141 | 2 | IPR007604 | |
| Domain | VWA | 8.43e-04 | 56 | 141 | 4 | PF00092 | |
| Domain | Recep_L_domain | 1.16e-03 | 7 | 141 | 2 | PF01030 | |
| Domain | Furin-like | 1.16e-03 | 7 | 141 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 1.16e-03 | 7 | 141 | 2 | IPR000494 | |
| Domain | Furin-like_Cys-rich_dom | 1.16e-03 | 7 | 141 | 2 | IPR006211 | |
| Domain | - | 1.16e-03 | 7 | 141 | 2 | 3.80.20.20 | |
| Domain | EF-hand-dom_pair | 1.53e-03 | 287 | 141 | 8 | IPR011992 | |
| Domain | Pectin_lyase_fold/virulence | 1.54e-03 | 8 | 141 | 2 | IPR011050 | |
| Domain | LAM_G_DOMAIN | 2.93e-03 | 38 | 141 | 3 | PS50025 | |
| Domain | Integrin_alpha | 2.98e-03 | 11 | 141 | 2 | PF00357 | |
| Domain | Tyr_kinase_rcpt_2_CS | 2.98e-03 | 11 | 141 | 2 | IPR002011 | |
| Domain | - | 3.16e-03 | 39 | 141 | 3 | 2.120.10.30 | |
| Domain | Laminin_G_2 | 3.39e-03 | 40 | 141 | 3 | PF02210 | |
| Domain | RECEPTOR_TYR_KIN_II | 3.55e-03 | 12 | 141 | 2 | PS00239 | |
| Domain | - | 3.71e-03 | 261 | 141 | 7 | 1.10.238.10 | |
| Domain | Recoverin | 4.18e-03 | 13 | 141 | 2 | IPR028846 | |
| Domain | PSI | 4.45e-03 | 44 | 141 | 3 | IPR016201 | |
| Domain | LamG | 4.45e-03 | 44 | 141 | 3 | SM00282 | |
| Domain | - | SEMA4D FLT3 NTRK1 INSRR ITGB4 SEMA3D IGSF22 HMCN1 NFATC1 RBPJ MYBPC1 SORL1 | 4.48e-03 | 663 | 141 | 12 | 2.60.40.10 |
| Domain | Ldl_recept_b | 4.85e-03 | 14 | 141 | 2 | PF00058 | |
| Domain | LDLRB | 4.85e-03 | 14 | 141 | 2 | PS51120 | |
| Domain | WH2 | 4.85e-03 | 14 | 141 | 2 | SM00246 | |
| Domain | 6-blade_b-propeller_TolB-like | 5.04e-03 | 46 | 141 | 3 | IPR011042 | |
| Domain | LY | 5.57e-03 | 15 | 141 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 5.57e-03 | 15 | 141 | 2 | IPR000033 | |
| Domain | Chemokine_rcpt | 6.34e-03 | 16 | 141 | 2 | IPR000355 | |
| Domain | Integrin_alpha_C_CS | 6.34e-03 | 16 | 141 | 2 | IPR018184 | |
| Domain | ASX_HYDROXYL | 6.98e-03 | 100 | 141 | 4 | PS00010 | |
| Domain | Ig-like_fold | SEMA4D FLT3 NTRK1 INSRR ITGB4 SEMA3D IGSF22 HMCN1 NFATC1 RBPJ MYBPC1 SORL1 | 7.28e-03 | 706 | 141 | 12 | IPR013783 |
| Domain | p53-like_TF_DNA-bd | 7.49e-03 | 53 | 141 | 3 | IPR008967 | |
| Pathway | REACTOME_RHOBTB2_GTPASE_CYCLE | 3.64e-05 | 25 | 108 | 4 | MM15606 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | GABRB1 GABRG2 GABRG3 ERBB3 FLT3 COL6A6 NTRK1 RICTOR TEC KIDINS220 SHC2 CLTC WASF1 HSP90AA1 | 5.37e-05 | 532 | 108 | 14 | M27870 |
| Pathway | WP_TNFALPHA_SIGNALING | 7.35e-05 | 92 | 108 | 6 | M39662 | |
| Pathway | WP_GABA_RECEPTOR_SIGNALING | 8.74e-05 | 31 | 108 | 4 | M39369 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | GABRB1 GABRD GABRG2 CYP3A4 GRIA4 RICTOR NRXN3 SLC25A12 NRXN1 NRXN2 CTTN | 1.16e-04 | 367 | 108 | 11 | M48346 |
| Pubmed | 7.40e-08 | 3 | 147 | 3 | 38891114 | ||
| Pubmed | 7.40e-08 | 3 | 147 | 3 | 31005376 | ||
| Pubmed | Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. | 7.40e-08 | 3 | 147 | 3 | 11944992 | |
| Pubmed | 7.40e-08 | 3 | 147 | 3 | 33058888 | ||
| Pubmed | Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules. | 7.40e-08 | 3 | 147 | 3 | 17035546 | |
| Pubmed | 7.40e-08 | 3 | 147 | 3 | 9448462 | ||
| Pubmed | Deletion of α-neurexin II results in autism-related behaviors in mice. | 7.40e-08 | 3 | 147 | 3 | 25423136 | |
| Pubmed | 7.40e-08 | 3 | 147 | 3 | 30858964 | ||
| Pubmed | Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. | 7.40e-08 | 3 | 147 | 3 | 12036300 | |
| Pubmed | Neurexin gene family variants as risk factors for autism spectrum disorder. | 7.40e-08 | 3 | 147 | 3 | 29045040 | |
| Pubmed | 7.40e-08 | 3 | 147 | 3 | 38571813 | ||
| Pubmed | 7.40e-08 | 3 | 147 | 3 | 35173587 | ||
| Pubmed | 7.40e-08 | 3 | 147 | 3 | 16406382 | ||
| Pubmed | Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals. | 7.40e-08 | 3 | 147 | 3 | 26446217 | |
| Pubmed | Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior. | 7.40e-08 | 3 | 147 | 3 | 34133920 | |
| Pubmed | 7.40e-08 | 3 | 147 | 3 | 28013231 | ||
| Pubmed | 7.40e-08 | 3 | 147 | 3 | 31812984 | ||
| Pubmed | β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling. | 7.40e-08 | 3 | 147 | 3 | 26213384 | |
| Pubmed | Neurexins are differentially expressed in the embryonic nervous system of mice. | 7.40e-08 | 3 | 147 | 3 | 7722633 | |
| Pubmed | SYT3 ITSN1 MATR3 UBR4 MSANTD2 GRIA4 CCDC177 TENM2 OPA1 NRXN1 GPR158 CLTC KCNMA1 EML1 BUB3 CTTN WASF1 HSP90AA1 | 1.48e-07 | 963 | 147 | 18 | 28671696 | |
| Pubmed | 2.95e-07 | 4 | 147 | 3 | 8786425 | ||
| Pubmed | Neurexins regulate presynaptic GABAB-receptors at central synapses. | 2.95e-07 | 4 | 147 | 3 | 33888718 | |
| Pubmed | Neurexins cluster Ca2+ channels within the presynaptic active zone. | 2.95e-07 | 4 | 147 | 3 | 32134527 | |
| Pubmed | 2.95e-07 | 4 | 147 | 3 | 32706374 | ||
| Pubmed | 2.95e-07 | 4 | 147 | 3 | 17347997 | ||
| Pubmed | 2.95e-07 | 4 | 147 | 3 | 35385735 | ||
| Pubmed | Postsynaptic N-methyl-D-aspartate receptor function requires alpha-neurexins. | 2.95e-07 | 4 | 147 | 3 | 14983056 | |
| Pubmed | GABRB1 GABRG2 VWA8 UBR4 GRIA4 RICTOR TENM2 OPA1 MADD EIF3CL HPCA NRXN1 SUGP2 GPR158 HPCAL1 CLTC CTTN WASF1 HSP90AA1 | 3.72e-07 | 1139 | 147 | 19 | 36417873 | |
| Pubmed | GABRD SEMA4D ERBB3 SMC1A ITSN1 UBR4 ACTN1 CREBBP MADD CHUK POLR3B OTOF DROSHA CLTC LRP2 CTTN PADI2 YME1L1 PREX1 HSP90AA1 | 5.30e-07 | 1285 | 147 | 20 | 35914814 | |
| Pubmed | GABRG2 SYT3 ITSN1 MATR3 ACTN1 GTPBP1 CCDC177 OPA1 JMY MADD EIF3CL HNRNPCL3 HPCA KIDINS220 SLC25A12 SUGP2 NRXN2 CLTC CTTN WASF1 HSP90AA1 | 6.95e-07 | 1431 | 147 | 21 | 37142655 | |
| Pubmed | 7.35e-07 | 5 | 147 | 3 | 36709330 | ||
| Pubmed | 7.35e-07 | 5 | 147 | 3 | 9223334 | ||
| Pubmed | 7.35e-07 | 5 | 147 | 3 | 28472659 | ||
| Pubmed | 7.35e-07 | 5 | 147 | 3 | 20537373 | ||
| Pubmed | Neuroligins and neurexins link synaptic function to cognitive disease. | 7.35e-07 | 5 | 147 | 3 | 18923512 | |
| Pubmed | 8.95e-07 | 18 | 147 | 4 | 18985723 | ||
| Pubmed | 1.47e-06 | 6 | 147 | 3 | 30683685 | ||
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 1.47e-06 | 6 | 147 | 3 | 12827191 | |
| Pubmed | Structures, alternative splicing, and neurexin binding of multiple neuroligins. | 1.47e-06 | 6 | 147 | 3 | 8576240 | |
| Pubmed | 1.49e-06 | 83 | 147 | 6 | 11114734 | ||
| Pubmed | 3.09e-06 | 94 | 147 | 6 | 25201988 | ||
| Pubmed | 3.63e-06 | 363 | 147 | 10 | 25036637 | ||
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 4.08e-06 | 8 | 147 | 3 | 30871858 | |
| Pubmed | 4.08e-06 | 8 | 147 | 3 | 37591863 | ||
| Pubmed | NCOA6 differentially regulates the expression of the CYP2C9 and CYP3A4 genes. | 4.08e-06 | 8 | 147 | 3 | 21292004 | |
| Pubmed | 4.26e-06 | 26 | 147 | 4 | 28087629 | ||
| Pubmed | 6.10e-06 | 9 | 147 | 3 | 34919427 | ||
| Pubmed | 6.10e-06 | 9 | 147 | 3 | 9707552 | ||
| Pubmed | 8.69e-06 | 10 | 147 | 3 | 20889973 | ||
| Pubmed | 8.69e-06 | 10 | 147 | 3 | 11964161 | ||
| Pubmed | TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson's disease. | 9.85e-06 | 67 | 147 | 5 | 34644545 | |
| Pubmed | A high-resolution radiation hybrid map of the proximal portion of mouse chromosome 5. | 1.14e-05 | 33 | 147 | 4 | 10843805 | |
| Pubmed | GABRG2 PCDHGA2 ITSN1 MATR3 UBR4 GRIA4 ACTN1 HNRNPCL3 CHUK HPCA NRXN3 SLC25A12 NRXN1 HPCAL1 CLTC CTTN PREX1 HSP90AA1 MYBPC1 | 1.15e-05 | 1442 | 147 | 19 | 35575683 | |
| Pubmed | 1.19e-05 | 11 | 147 | 3 | 32973045 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ERCC3 VWA8 SMC1A MATR3 MED1 OPA1 KIDINS220 SLC25A12 NRXN1 SUGP2 NRXN2 DROSHA CLTC BUB3 CATSPERG HSP90AA1 | 1.49e-05 | 1082 | 147 | 16 | 38697112 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ERCC3 SMC1A MATR3 UBR4 RICTOR ACTN1 CREBBP POLR3B SLC25A12 UBN1 SUGP2 CLTC PPP1R37 POLR1B TAF2 BUB3 YME1L1 HSP90AA1 | 1.75e-05 | 1353 | 147 | 18 | 29467282 |
| Pubmed | Association of ITGAX and ITGAM gene polymorphisms with susceptibility to IgA nephropathy. | 1.77e-05 | 2 | 147 | 2 | 31227791 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 37543682 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 15985311 | ||
| Pubmed | Notch signaling regulates CXCR4 expression and the migration of mesenchymal stem cells. | 1.77e-05 | 2 | 147 | 2 | 23474530 | |
| Pubmed | GABA(A)R plasticity during pregnancy: relevance to postpartum depression. | 1.77e-05 | 2 | 147 | 2 | 18667149 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 8573344 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 30709877 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 34969760 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 19415696 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 34906163 | ||
| Pubmed | Two novel GABAA receptor subunits exist in distinct neuronal subpopulations. | 1.77e-05 | 2 | 147 | 2 | 2561970 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 23565284 | ||
| Pubmed | Identification of new OPA1 cleavage site reveals that short isoforms regulate mitochondrial fusion. | 1.77e-05 | 2 | 147 | 2 | 33237841 | |
| Pubmed | HNF4α is a novel regulator of intestinal glucose-dependent insulinotropic polypeptide. | 1.77e-05 | 2 | 147 | 2 | 30862908 | |
| Pubmed | The delta subunit of the GABAA receptor is necessary for the GPT2-promoted breast cancer metastasis. | 1.77e-05 | 2 | 147 | 2 | 36923530 | |
| Pubmed | Human Txk: genomic organization, structure and contiguous physical linkage with the Tec gene. | 1.77e-05 | 2 | 147 | 2 | 8632917 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 26393574 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 10085149 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 22882618 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 31147611 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 32484592 | ||
| Pubmed | Functional association between CBP and HNF4 in trans-activation. | 1.77e-05 | 2 | 147 | 2 | 9434765 | |
| Pubmed | Locus category based analysis of a large genome-wide association study of rheumatoid arthritis. | 1.77e-05 | 2 | 147 | 2 | 20639398 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 37958656 | ||
| Pubmed | SOX13 dependent PAX8 expression promotes the proliferation of gastric carcinoma cells. | 1.77e-05 | 2 | 147 | 2 | 31353958 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 12107181 | ||
| Pubmed | Postsynaptic clustering of gamma-aminobutyric acid type A receptors by the gamma3 subunit in vivo. | 1.77e-05 | 2 | 147 | 2 | 10536013 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 26434625 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 18394702 | ||
| Pubmed | NGF/TrkA-mediated Kidins220/ARMS signaling activated in the allergic airway challenge in mice. | 1.77e-05 | 2 | 147 | 2 | 20934630 | |
| Pubmed | Neurexin I alpha is a major alpha-latrotoxin receptor that cooperates in alpha-latrotoxin action. | 1.77e-05 | 2 | 147 | 2 | 9430716 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 34283878 | ||
| Pubmed | Angiotensin II Stimulation of DPP4 Activity Regulates Megalin in the Proximal Tubules. | 1.77e-05 | 2 | 147 | 2 | 27213360 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 30241936 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 19658047 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 19357083 | ||
| Pubmed | PEA3 activates CXCR4 transcription in MDA-MB-231 and MCF7 breast cancer cells. | 1.77e-05 | 2 | 147 | 2 | 21831961 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 36395406 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 15054042 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 26595880 | ||
| Pubmed | Impact of CXCR4 inhibition on FLT3-ITD-positive human AML blasts. | 1.77e-05 | 2 | 147 | 2 | 20035824 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 36241903 | ||
| Pubmed | Neurocalcin family: a novel calcium-binding protein abundant in bovine central nervous system. | 1.77e-05 | 2 | 147 | 2 | 8387172 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 18541300 | ||
| Interaction | MET interactions | DPP4 ERBB3 SMC1A UBR4 RICTOR TEC ITGB4 TXK SHC2 GPR158 CTTN HSP90AA1 | 1.04e-06 | 290 | 142 | 12 | int:MET |
| Cytoband | 4p12 | 3.52e-05 | 20 | 147 | 3 | 4p12 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 3.47e-06 | 19 | 102 | 4 | 563 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 7.72e-05 | 394 | 102 | 10 | 471 | |
| GeneFamily | EF-hand domain containing | 2.42e-04 | 219 | 102 | 7 | 863 | |
| GeneFamily | Fibronectin type III domain containing | 2.92e-04 | 160 | 102 | 6 | 555 | |
| GeneFamily | RNA polymerase subunits | 5.73e-04 | 29 | 102 | 3 | 726 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.48e-03 | 40 | 102 | 3 | 321 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 3.59e-03 | 16 | 102 | 2 | 14 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | GABRG2 PDE1A COL6A6 GRIA4 RICTOR CSMD2 TENM2 HNRNPCL3 CEMIP PPP2R2B NRXN3 SLC25A12 NRXN1 SUGP2 NRXN2 GPR158 PKIA KCNMA1 CATSPERG WASF1 | 2.84e-06 | 1106 | 144 | 20 | M39071 |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 1.26e-05 | 323 | 144 | 10 | M9150 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-41|World / Primary Cells by Cluster | 1.93e-08 | 196 | 147 | 9 | dee0984cd63a1a2fdebb4421af48ab566a5b684e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 2.01e-08 | 197 | 147 | 9 | 4961f66606f08e399508fd6cabca588e7ab406a8 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal|10w / Sample Type, Dataset, Time_group, and Cell type. | 2.29e-08 | 200 | 147 | 9 | 979258173b82f37aeaaedd53b4a527da1dbe1b80 | |
| ToppCell | RA-16._Neuronal|RA / Chamber and Cluster_Paper | 1.56e-07 | 180 | 147 | 8 | 5842febfdabac61ce970254fb0ef17a628f1b8c0 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.36e-07 | 190 | 147 | 8 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.55e-07 | 192 | 147 | 8 | b7c01e12b3e9be960a741b08835f1dfff65d0d47 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 3.10e-07 | 197 | 147 | 8 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 3.10e-07 | 197 | 147 | 8 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.23e-07 | 198 | 147 | 8 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.17e-07 | 151 | 147 | 7 | f13a117ae26ae525da4f3e837d8f204d00dc6ee3 | |
| ToppCell | Control-Lymphocytic_NKT-T_cells-T-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-06 | 178 | 147 | 7 | 910f8bea19d335455aba24e6a07b4834b709db5d | |
| ToppCell | Control-Lymphocytic_NKT-T_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.23e-06 | 179 | 147 | 7 | d892d9496f1c33e23312092591eb2e968e736f7d | |
| ToppCell | LPS_only-Lymphocytic_NKT-T_cells-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-06 | 180 | 147 | 7 | dcef253f2e97e4436b1b04e8a06a53ff6e64522c | |
| ToppCell | RA-16._Neuronal|World / Chamber and Cluster_Paper | 2.41e-06 | 181 | 147 | 7 | 7d22a43f887e0747f0cb87ba364ff27905ee6eec | |
| ToppCell | LPS_only-Lymphocytic_NKT-T_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.41e-06 | 181 | 147 | 7 | a4347ae554e6dcf03c7001a2b69332b377c7c034 | |
| ToppCell | RA-17._Lymphocyte|World / Chamber and Cluster_Paper | 2.59e-06 | 183 | 147 | 7 | 6397f684a50346fc42cccb5afbe10350f4b2d9b0 | |
| ToppCell | Cerebellum-Neuronal|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.99e-06 | 187 | 147 | 7 | 61b9d6eb131a674598aa8409d7fa909c8765442d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.20e-06 | 189 | 147 | 7 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | COVID-19-Heart-T_cell|Heart / Disease (COVID-19 only), tissue and cell type | 3.32e-06 | 190 | 147 | 7 | e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-06 | 191 | 147 | 7 | 297bc79adc5fef211497819b4861b52cd26ac754 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-06 | 191 | 147 | 7 | e1ec165ba6578cefd88895e7e183190e79f733a4 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.43e-06 | 191 | 147 | 7 | 9c747f8cc1cdce45e839b661d782e1e8cfb79578 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial-Intermediate_lymphatic_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.43e-06 | 191 | 147 | 7 | d25ac3206fe205a100cfee26431ff32c14c1938f | |
| ToppCell | COVID-19-kidney-Myeloid|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.55e-06 | 192 | 147 | 7 | 0b9d22a222f1201e375f8e55cace9ef939febae4 | |
| ToppCell | Control-B_memory-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.57e-06 | 124 | 147 | 6 | 3e987915026f503e8d072a837b6e7a34252e5c63 | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 3.68e-06 | 193 | 147 | 7 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.68e-06 | 193 | 147 | 7 | 4b8202fcfe639a73f69a13f48fc3601ade256346 | |
| ToppCell | RA-08._Macrophage|RA / Chamber and Cluster_Paper | 3.80e-06 | 194 | 147 | 7 | ac26e5c71d5069622de72fa25a9c920887ac2c19 | |
| ToppCell | LA-08._Macrophage|LA / Chamber and Cluster_Paper | 3.94e-06 | 195 | 147 | 7 | 5e1d5bdb8874091f5a2b1d0a8cc9008165718a97 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.94e-06 | 195 | 147 | 7 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.94e-06 | 195 | 147 | 7 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.07e-06 | 196 | 147 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | ILEUM-non-inflamed-(6)_ILC-(6)_ILC1|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.07e-06 | 196 | 147 | 7 | 8a3a63129adfbe58558af91336f81d397c291ed0 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-37|World / Primary Cells by Cluster | 4.21e-06 | 197 | 147 | 7 | 00d756bc0231e1b3b88430214338c1059cb11106 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-Neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 4.35e-06 | 198 | 147 | 7 | 90ebefc9ba8dc2a81471e5693384f5ce56f06298 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.35e-06 | 198 | 147 | 7 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.35e-06 | 198 | 147 | 7 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Control-Control-Myeloid-Neutrophil|Control / Disease, condition lineage and cell class | 4.65e-06 | 200 | 147 | 7 | 95c41f147a1594d49e73cb56d86d301c3115ce20 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 4.65e-06 | 200 | 147 | 7 | 68c90376e2779434e4ad8dc6dd3b44baa700e2f4 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 4.65e-06 | 200 | 147 | 7 | ac0e023dbb383bbc46c5cc525431778be8f7ef46 | |
| ToppCell | severe-Myeloid-Neutrophils_4|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.65e-06 | 200 | 147 | 7 | b665f36dcf3c9d3981ee96f2973512f751612542 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.65e-06 | 200 | 147 | 7 | 29054cf55e88e1ac81a562d8dd9af9b7c749321d | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.50e-06 | 147 | 147 | 6 | 9d7e965fe61bd7b31e09c4b2129a5a98c36f4811 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.50e-06 | 147 | 147 | 6 | 38552953ff65a0fc20bee6ef57dc5885306ad18b | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.88e-06 | 148 | 147 | 6 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-05 | 150 | 147 | 6 | 6e806a028c0519489151c181d9907e05289e27e0 | |
| ToppCell | RV-16._Neuronal|RV / Chamber and Cluster_Paper | 1.19e-05 | 153 | 147 | 6 | bed8bbf5c5cbfbf46a816066da472c3fdddecb5d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.49e-05 | 159 | 147 | 6 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 163 | 147 | 6 | 2e1c1193c04620cc187b1567dfba025beef1e4e1 | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 164 | 147 | 6 | 1250876abd7311f86730e5b9c03c3610cc2ff6d3 | |
| ToppCell | facs-MAT-Fat-3m-Myeloid|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 164 | 147 | 6 | fa0d77b648cde5e42b9394e877168c80de238bde | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 1.83e-05 | 165 | 147 | 6 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_bronchial_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.90e-05 | 166 | 147 | 6 | a697460dfe72e08fbf7d8e734a16b7dd2c6d86f9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 168 | 147 | 6 | 61a5435b27b01ff1a509ea463a6af220c5d2c9b3 | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 2.03e-05 | 168 | 147 | 6 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 168 | 147 | 6 | 26fce414439ccd204e3acb41f2b4f75072df5a26 | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | 2.03e-05 | 168 | 147 | 6 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.10e-05 | 169 | 147 | 6 | 20b17f1d6d845213479ade09ea0c7ecc277a73c6 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.10e-05 | 169 | 147 | 6 | 3e40ae0b23a962e0f15908872dec63f51c5b8b83 | |
| ToppCell | LV-16._Neuronal|LV / Chamber and Cluster_Paper | 2.10e-05 | 169 | 147 | 6 | a8fc8ab0f0757e939e213efb61c03cfe390bf7d2 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-05 | 171 | 147 | 6 | 539ea88acc6f948efdeae8b69e5c5ffaee29f1d9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_THEMIS_PLA2G7|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.32e-05 | 172 | 147 | 6 | 1d086e00cd549459d70e1d3b468d5ab6379f3bee | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-05 | 172 | 147 | 6 | 0fc692be845d4225ff8b63bf9195724fc8510c2c | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 173 | 147 | 6 | 63f03abca84ae021ff34ff34537838aa8a1ccd11 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-iNKT/MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.47e-05 | 174 | 147 | 6 | 61aa89b56ebda0eba1ba675d5f036992967f670f | |
| ToppCell | Control-CD4+_T_activated|Control / Disease group and Cell class | 2.47e-05 | 174 | 147 | 6 | 2b683e81b315ad22555314433aed5681feb48da8 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.47e-05 | 174 | 147 | 6 | ccc79febfcf588d8294ffc712338be96de8a5033 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-05 | 175 | 147 | 6 | 98cb577df466700e72d1bbc6689205ccf2e7fcba | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-05 | 176 | 147 | 6 | 74f851a398c7562dd713bc0d8d488c0037243112 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-05 | 176 | 147 | 6 | bb41e9478373726eb460af764de0277b2d09928e | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-05 | 176 | 147 | 6 | 31b5459a978d5cdde0af03a77401e0464d8c95ba | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Neutrophil|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-05 | 177 | 147 | 6 | ed44b1bf2ffae97f94e944d1b6060d5163eba6a6 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.81e-05 | 178 | 147 | 6 | f914092c20130207193f97c6044ae61a9a440a86 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.81e-05 | 178 | 147 | 6 | 7905621f5b2aa55324c5592d1d2fef763a5fa41f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-05 | 178 | 147 | 6 | dfed0fbf7a73b8a9e00178ec58dc4592b271c344 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.81e-05 | 178 | 147 | 6 | 73936c2e7e8855b4ab65cad425686513dba331a3 | |
| ToppCell | LPS_only-Lymphocytic_NKT-iNKT/MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.90e-05 | 179 | 147 | 6 | de3ddc1264e43727be50d69b81cc84a3c91812a2 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Microfold_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.90e-05 | 179 | 147 | 6 | c7d7a66fca6a41de0af3cc2b75a29a54456842cd | |
| ToppCell | LPS_only-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.90e-05 | 179 | 147 | 6 | def981e97e3ff9019910c9af3861ca0d08eb0d0f | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 180 | 147 | 6 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-05 | 180 | 147 | 6 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 180 | 147 | 6 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | Control-Myeloid-Dendritic_cells|Control / group, cell type (main and fine annotations) | 2.99e-05 | 180 | 147 | 6 | 25ad95c3c30e3b82abe93bd77ba003f5c2241f7c | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-05 | 181 | 147 | 6 | cef034030e6b029a49ae56be37ea1fac1a5c350e | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-05 | 181 | 147 | 6 | 782716b8b1d447d2bbe09a693fa5ed7ebeac0efb | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-05 | 181 | 147 | 6 | e2481291c236105774c53883e6f20da11941df9b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-Treg|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.08e-05 | 181 | 147 | 6 | 3754970d62eea1d2522b11d977eea4362f90d21e | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.18e-05 | 182 | 147 | 6 | bfb725fff3d20066d8ac0a6ba2f88498fcbd876e | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 182 | 147 | 6 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | RA-17._Lymphocyte|RA / Chamber and Cluster_Paper | 3.18e-05 | 182 | 147 | 6 | 257a7847917b6ea1d60608183d90300bfd028758 | |
| ToppCell | Control-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.28e-05 | 183 | 147 | 6 | 2c5707ada3442eb7100a2a5f9438d5a2ac53a9e1 | |
| ToppCell | IPF-Lymphoid-ILC_A|IPF / Disease state, Lineage and Cell class | 3.28e-05 | 183 | 147 | 6 | 49bfeaae13eb236f61a5486ee75c39789936bb8a | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 183 | 147 | 6 | 7eaa6ef7c6cf848fd6489f97677f4406318da22f | |
| ToppCell | Control-Lymphocytic_NKT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.48e-05 | 185 | 147 | 6 | 59d68e119f58b35bab36294758f6b2e25fd8f5c0 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.48e-05 | 185 | 147 | 6 | f9f48251bc33eb6bf2cff580d1a3207d21450aa0 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.59e-05 | 186 | 147 | 6 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.59e-05 | 186 | 147 | 6 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.59e-05 | 186 | 147 | 6 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-05 | 187 | 147 | 6 | b93cf4dfe8ffb89348ee7bccc9f284189f7240a2 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.70e-05 | 187 | 147 | 6 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| Drug | 3-isothujone | 2.90e-08 | 30 | 143 | 6 | CID000011027 | |
| Drug | 5 beta-pregnanediol | 9.73e-08 | 60 | 143 | 7 | CID000012547 | |
| Drug | sevoflurane | 3.32e-07 | 105 | 143 | 8 | CID000005206 | |
| Drug | thymol | 4.21e-07 | 46 | 143 | 6 | CID000006989 | |
| Drug | Androgen Antagonists | 4.62e-07 | 75 | 143 | 7 | ctd:D000726 | |
| Drug | Ipratropium bromide [22254-24-6]; Up 200; 9.8uM; PC3; HT_HG-U133A | CNNM2 SMC1A ISG20 PPP2R2B NRXN3 SHC2 NFATC1 PAX8 CTTN CCDC33 | 4.93e-07 | 197 | 143 | 10 | 5823_UP |
| Drug | Linuron | 1.51e-06 | 128 | 143 | 8 | ctd:D008044 | |
| Drug | sodium linoleate | ERBB3 CYP3A4 CTSC MED1 CPT1A CHKB ITGAM ITGAX KCNMA1 LRP2 SLC27A5 SORL1 | 1.78e-06 | 342 | 143 | 12 | CID000003931 |
| Drug | AC1L2FYN | 1.88e-06 | 33 | 143 | 5 | CID000071333 | |
| Drug | dihydroxyaflavinine | 3.33e-06 | 17 | 143 | 4 | CID000156857 | |
| Drug | Dichlorodiphenyl Dichloroethylene | GABRB1 ERBB3 CYP3A4 NTRK1 APAF1 GRIA4 ACTN1 CPT1A CREBBP NRXN1 NRXN2 | 3.41e-06 | 302 | 143 | 11 | ctd:D003633 |
| Drug | DMCM | 3.87e-06 | 38 | 143 | 5 | CID000104999 | |
| Drug | zaleplon | 4.42e-06 | 39 | 143 | 5 | CID000005719 | |
| Drug | endrine | 4.83e-06 | 106 | 143 | 7 | CID000003048 | |
| Drug | felbamate | 5.21e-06 | 70 | 143 | 6 | CID000003331 | |
| Drug | procymidone | 6.29e-06 | 155 | 143 | 8 | ctd:C035988 | |
| Drug | zolpidem | 7.24e-06 | 43 | 143 | 5 | CID000005732 | |
| Drug | sitagliptin | 8.12e-06 | 44 | 143 | 5 | CID004369359 | |
| Drug | heptachlor epoxide | 1.02e-05 | 46 | 143 | 5 | CID000013930 | |
| Drug | gabapentin | 1.19e-05 | 169 | 143 | 8 | CID000003446 | |
| Drug | fenofibric acid | 1.39e-05 | 49 | 143 | 5 | CID000064929 | |
| Drug | vigabatrin | 1.39e-05 | 49 | 143 | 5 | CID000005665 | |
| Drug | methohexital | 1.44e-05 | 24 | 143 | 4 | CID000009034 | |
| Drug | enzacamene | 1.76e-05 | 129 | 143 | 7 | ctd:C038939 | |
| Drug | metformin | 1.83e-05 | 235 | 143 | 9 | CID000004091 | |
| Drug | neostigmine | 1.84e-05 | 87 | 143 | 6 | CID000004456 | |
| Drug | picrotoxin | 1.95e-05 | 181 | 143 | 8 | CID000031304 | |
| Drug | endosulfan | 1.96e-05 | 88 | 143 | 6 | CID000003224 | |
| Drug | triazolam | 2.25e-05 | 54 | 143 | 5 | CID000005556 | |
| Drug | X1043 | 2.82e-05 | 10 | 143 | 3 | CID011235728 | |
| Drug | octylmethoxycinnamate | 2.85e-05 | 139 | 143 | 7 | ctd:C118580 | |
| Drug | Dichlorodiphenyldichloroethane | 3.14e-05 | 29 | 143 | 4 | ctd:D003632 | |
| Drug | flunitrazepam | 3.47e-05 | 59 | 143 | 5 | CID000003380 | |
| Drug | Pinacidil [85371-64-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 3.57e-05 | 197 | 143 | 8 | 5456_UP | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; HL60; HG-U133A | 3.70e-05 | 198 | 143 | 8 | 1377_UP | |
| Drug | simvastatin | SELE CYP3A4 CCR9 HNF4A CHUK SLC22A8 CXCR4 LRP2 GPT2 HSP90AA1 SORL1 | 3.71e-05 | 390 | 143 | 11 | CID000054454 |
| Drug | I vs | 4.07e-05 | 147 | 143 | 7 | CID000444340 | |
| Drug | cyclothiazide | 4.79e-05 | 103 | 143 | 6 | CID000002910 | |
| Drug | CGS 8216 | 5.30e-05 | 33 | 143 | 4 | CID000104916 | |
| Drug | taxol | SEMA4D ERBB3 CYP3A4 APAF1 TEC ITGB4 CHUK ITFG1 NRK RBPJ TTC32 BUB3 HSP90AA1 | 5.44e-05 | 560 | 143 | 13 | CID000004666 |
| Drug | picrotoxinine | 5.56e-05 | 65 | 143 | 5 | CID000004816 | |
| Drug | butylparaben | 6.19e-05 | 157 | 143 | 7 | ctd:C038091 | |
| Drug | ifosfamide | 6.43e-05 | 67 | 143 | 5 | CID000003690 | |
| Drug | vitamin D3 | 6.61e-05 | 277 | 143 | 9 | CID000002735 | |
| Drug | flurazepam | 6.71e-05 | 35 | 143 | 4 | CID000003393 | |
| Drug | secobarbital | 8.39e-05 | 37 | 143 | 4 | CID000005193 | |
| Drug | Me-lex | 8.39e-05 | 14 | 143 | 3 | CID000004177 | |
| Drug | DMAEMA | 8.39e-05 | 14 | 143 | 3 | CID000017869 | |
| Drug | tetrachlorophenol | 8.39e-05 | 14 | 143 | 3 | CID000021013 | |
| Drug | AC1L322F | 1.04e-04 | 15 | 143 | 3 | CID000133040 | |
| Drug | Gabrene | 1.14e-04 | 40 | 143 | 4 | CID005361323 | |
| Drug | lapachenole | 1.17e-04 | 3 | 143 | 2 | CID000174859 | |
| Drug | Hexobarbital | 1.17e-04 | 3 | 143 | 2 | ctd:D006591 | |
| Drug | 4-(dimethylamino)benzoic acid | 1.17e-04 | 3 | 143 | 2 | CID000012092 | |
| Drug | nesina | 1.17e-04 | 3 | 143 | 2 | CID016088021 | |
| Drug | gaboxadol | 1.26e-04 | 41 | 143 | 4 | CID000003448 | |
| Drug | 3,6,9,12,15-pentaoxaheptadecan-1-ol | 1.26e-04 | 41 | 143 | 4 | CID000078058 | |
| Drug | nimetazepam | 1.28e-04 | 16 | 143 | 3 | CID000004496 | |
| Drug | 3-hydroxy-3-methylglutaryl-CoA | 1.30e-04 | 237 | 143 | 8 | CID000000084 | |
| Drug | 17-isoprogesterone | GABRB1 GABRD GABRG2 GABRG3 DPP4 ERBB3 CYP3A4 PCDHGA2 APAF1 ETV4 GRIA4 ACTN1 ITGB4 CXCR4 KCNMA1 POLR1B SLC2A13 TAF2 HSP90AA1 | 1.36e-04 | 1170 | 143 | 19 | CID000004920 |
| Drug | 5 beta-alphaxalone | 1.39e-04 | 42 | 143 | 4 | CID000068930 | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 1.41e-04 | 179 | 143 | 7 | 5590_UP | |
| Drug | bis(tri-n-butyltin)oxide | GABRG3 SMC1A MATR3 APAF1 PORCN ISG20 ACTN1 HNF4A CREBBP NFATC1 CXCR4 POLR1B | 1.54e-04 | 538 | 143 | 12 | ctd:C005961 |
| Drug | zolpidem | 1.55e-04 | 17 | 143 | 3 | ctd:C049109 | |
| Drug | colchine | GABRB1 SELE GABRD GABRG2 GABRG3 ISG20 LRP2 GRHL3 GPT2 YME1L1 | 1.59e-04 | 383 | 143 | 10 | CID000002833 |
| Drug | lorazepam | 1.67e-04 | 44 | 143 | 4 | CID000003958 | |
| Drug | clonazepam | 1.69e-04 | 82 | 143 | 5 | CID000002802 | |
| Drug | nevirapine | 1.82e-04 | 45 | 143 | 4 | CID000004463 | |
| Drug | buformin | 1.85e-04 | 18 | 143 | 3 | CID000002468 | |
| Drug | AC1L3X9U | 1.85e-04 | 18 | 143 | 3 | CID000096811 | |
| Drug | Methoxychlor | GABRD CYP3A4 SMC1A ITSN1 INSRR MED1 ITGAM HPCAL1 CXCR4 KCNMA1 WASF1 HSP90AA1 | 1.86e-04 | 549 | 143 | 12 | ctd:D008731 |
| Drug | AC1L1B1W | 1.89e-04 | 84 | 143 | 5 | CID000001248 | |
| Drug | 17alpha-estradiol | GABRB1 SELE GABRD ERICH1 GABRG2 GABRG3 ERBB3 CEBPD CYP3A4 NTRK1 CCR9 ISG20 MED1 GIP CXCR4 KCNMA1 LRP2 TAF2 GPT2 SORL1 | 1.91e-04 | 1303 | 143 | 20 | CID000000450 |
| Disease | rheumatoid arthritis | DPP4 ERBB3 FLT3 NTRK1 TEC GRHL2 MB21D2 NFATC1 RBPJ PADI2 PREX1 TEC | 2.25e-06 | 462 | 140 | 12 | EFO_0000685 |
| Disease | Schizophrenia | GABRB1 GABRD GABRG2 ERBB3 CNNM2 CYP3A4 NTRK1 GRIA4 CSMD2 ITGAM OPA1 SEMA3D NRXN3 NRXN1 NRXN2 LRP2 | 4.85e-06 | 883 | 140 | 16 | C0036341 |
| Disease | alcohol use disorder (implicated_via_orthology) | 4.23e-05 | 195 | 140 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | Acute Promyelocytic Leukemia | 6.79e-05 | 46 | 140 | 4 | C0023487 | |
| Disease | cystathionine measurement | 9.58e-05 | 19 | 140 | 3 | EFO_0010474 | |
| Disease | Fanconi syndrome (implicated_via_orthology) | 1.33e-04 | 4 | 140 | 2 | DOID:1062 (implicated_via_orthology) | |
| Disease | tyrosine-protein kinase TEC measurement | 1.33e-04 | 4 | 140 | 2 | EFO_0020830 | |
| Disease | uric acid measurement | PDE1A CNNM2 NTRK1 INSRR HNF4A TENM2 CEMIP NRXN2 NFATC1 LRP2 SLC27A5 | 1.65e-04 | 610 | 140 | 11 | EFO_0004761 |
| Disease | C-reactive protein measurement | SEMA4D CYP3A4 VPS13C CAPSL NAGLU RICTOR MON1A GTPBP1 HNF4A JMY MADD EIF3CL GIP PAX8 PPP1R37 POLR1B | 2.01e-04 | 1206 | 140 | 16 | EFO_0004458 |
| Disease | Autistic Disorder | 2.58e-04 | 261 | 140 | 7 | C0004352 | |
| Disease | colorectal adenocarcinoma (is_marker_for) | 2.81e-04 | 27 | 140 | 3 | DOID:0050861 (is_marker_for) | |
| Disease | Intellectual Disability | 2.96e-04 | 447 | 140 | 9 | C3714756 | |
| Disease | visceral adipose tissue measurement | 5.02e-04 | 481 | 140 | 9 | EFO_0004765 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 6.97e-04 | 147 | 140 | 5 | DOID:9352 (biomarker_via_orthology) | |
| Disease | glycosyl-N-palmitoyl-sphingosine (d18:1/16:0) measurement | 7.87e-04 | 9 | 140 | 2 | EFO_0800476 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 7.87e-04 | 9 | 140 | 2 | C3502809 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 8.10e-04 | 152 | 140 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | ejection fraction measurement | 1.12e-03 | 43 | 140 | 3 | EFO_0005527 | |
| Disease | forced expiratory volume, response to bronchodilator | 1.33e-03 | 445 | 140 | 8 | EFO_0004314, GO_0097366 | |
| Disease | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | 1.33e-03 | 170 | 140 | 5 | EFO_0000685, EFO_0007791, EFO_0007837 | |
| Disease | Adenoid Cystic Carcinoma | 1.34e-03 | 100 | 140 | 4 | C0010606 | |
| Disease | lymphangioleiomyomatosis (is_marker_for) | 1.43e-03 | 12 | 140 | 2 | DOID:3319 (is_marker_for) | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 1.43e-03 | 12 | 140 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | GABRB1 PDE1A ERBB3 CNNM2 GRIA4 TENM2 CEMIP2 NRXN3 NRXN1 NRXN2 SORL1 | 1.57e-03 | 801 | 140 | 11 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.64e-03 | 49 | 140 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Diverticular Bleeding | 1.68e-03 | 13 | 140 | 2 | C4505353 | |
| Disease | Fulminant Hepatic Failure with Cerebral Edema | 1.68e-03 | 13 | 140 | 2 | C0751197 | |
| Disease | Hepatic Stupor | 1.68e-03 | 13 | 140 | 2 | C0751198 | |
| Disease | hyperglycemia (is_marker_for) | 1.68e-03 | 13 | 140 | 2 | DOID:4195 (is_marker_for) | |
| Disease | Diverticular Diseases | 1.68e-03 | 13 | 140 | 2 | C4317009 | |
| Disease | Hepatic Encephalopathy | 1.68e-03 | 13 | 140 | 2 | C0019151 | |
| Disease | Hepatic Coma | 1.68e-03 | 13 | 140 | 2 | C0019147 | |
| Disease | Skin Abnormalities | 1.68e-03 | 13 | 140 | 2 | C0037268 | |
| Disease | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement | 1.68e-03 | 13 | 140 | 2 | EFO_0800284 | |
| Disease | Tourette syndrome | 1.74e-03 | 50 | 140 | 3 | EFO_0004895 | |
| Disease | Malignant neoplasm of breast | ERBB3 ERCC3 SYT3 CYP3A4 UBR4 ETV4 CPT1A OTOF CXCR4 ZFYVE26 CLSPN HSP90AA1 SORL1 | 1.85e-03 | 1074 | 140 | 13 | C0006142 |
| Disease | Metabolic Bone Disorder | 1.96e-03 | 14 | 140 | 2 | C0005944 | |
| Disease | Drug habituation | 2.23e-03 | 115 | 140 | 4 | C0013170 | |
| Disease | Drug abuse | 2.23e-03 | 115 | 140 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 2.23e-03 | 115 | 140 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 2.23e-03 | 115 | 140 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 2.23e-03 | 115 | 140 | 4 | C0013222 | |
| Disease | Drug Dependence | 2.23e-03 | 115 | 140 | 4 | C1510472 | |
| Disease | Substance Dependence | 2.23e-03 | 115 | 140 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 2.23e-03 | 115 | 140 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 2.23e-03 | 115 | 140 | 4 | C0029231 | |
| Disease | Osteopenia | 2.25e-03 | 15 | 140 | 2 | C0029453 | |
| Disease | glycerate measurement | 2.25e-03 | 15 | 140 | 2 | EFO_0021029 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 2.25e-03 | 15 | 140 | 2 | DOID:13413 (biomarker_via_orthology) | |
| Disease | Substance abuse problem | 2.30e-03 | 116 | 140 | 4 | C0740858 | |
| Disease | Neuralgia, Supraorbital | 2.57e-03 | 16 | 140 | 2 | C0038870 | |
| Disease | Neuralgia | 2.57e-03 | 16 | 140 | 2 | C0027796 | |
| Disease | Neuralgia, Atypical | 2.57e-03 | 16 | 140 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 2.57e-03 | 16 | 140 | 2 | C0234249 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 2.57e-03 | 16 | 140 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 2.57e-03 | 16 | 140 | 2 | C0423711 | |
| Disease | Paroxysmal Nerve Pain | 2.57e-03 | 16 | 140 | 2 | C0751373 | |
| Disease | Nerve Pain | 2.57e-03 | 16 | 140 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 2.57e-03 | 16 | 140 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 2.57e-03 | 16 | 140 | 2 | C0042656 | |
| Disease | IGA glomerulonephritis | 2.67e-03 | 58 | 140 | 3 | EFO_0004194 | |
| Disease | narcolepsy-cataplexy syndrome | 2.80e-03 | 59 | 140 | 3 | MONDO_0016158 | |
| Disease | colon cancer (is_marker_for) | 2.80e-03 | 59 | 140 | 3 | DOID:219 (is_marker_for) | |
| Disease | Multiple congenital anomalies | 2.90e-03 | 17 | 140 | 2 | C0000772 | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 3.63e-03 | 19 | 140 | 2 | OBA_2045199 | |
| Disease | Alzheimer's disease (is_implicated_in) | 3.67e-03 | 132 | 140 | 4 | DOID:10652 (is_implicated_in) | |
| Disease | Dermatitis, Allergic Contact | 4.01e-03 | 67 | 140 | 3 | C0162820 | |
| Disease | Hematochezia, response to radiation | 4.02e-03 | 20 | 140 | 2 | GO_0009314, HP_0002573 | |
| Disease | androsterone glucuronide measurement | 4.02e-03 | 20 | 140 | 2 | EFO_0800317 | |
| Disease | lymphocyte count | ERBB3 FLT3 CYP3A4 PCDHGA2 NTRK1 INSRR GRHL2 SEMA3D NRXN2 NFATC1 PAX8 CXCR4 POLR1B DMRTA1 PREX1 | 4.13e-03 | 1464 | 140 | 15 | EFO_0004587 |
| Disease | schizophrenia (implicated_via_orthology) | 4.18e-03 | 68 | 140 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | Profound Mental Retardation | 4.41e-03 | 139 | 140 | 4 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 4.41e-03 | 139 | 140 | 4 | C0025363 | |
| Disease | Mental deficiency | 4.41e-03 | 139 | 140 | 4 | C0917816 | |
| Disease | forced expiratory volume | CYP3A4 PARD3B MED1 NRXN3 CXCR4 DROSHA KCNMA1 PREX1 HSP90AA1 MYBPC1 | 4.49e-03 | 789 | 140 | 10 | EFO_0004314 |
| Disease | smoking cessation | 4.66e-03 | 325 | 140 | 6 | EFO_0004319 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YEMGPEYSSNVELAS | 321 | Q8TD30 | |
| SSSYDYEALDEAMSI | 356 | O14727 | |
| YASNETMLTLFYEDS | 571 | Q6ZRH7 | |
| STQEMYFYDGVSRDA | 346 | Q86X53 | |
| SLEELGYEYMDVGSD | 1216 | P21860 | |
| GYEYMDVGSDLSASL | 1221 | P21860 | |
| VNSDYETYMSADDLR | 181 | Q00005 | |
| ALDYMSFSTALYGES | 876 | P12814 | |
| MEGISIYTSDNYTEE | 1 | P61073 | |
| IYTSDNYTEEMGSGD | 6 | P61073 | |
| SMSYEGFNITFSEYD | 1021 | Q7Z408 | |
| YYSGVSASMNTDEEF | 251 | Q13938 | |
| EDTALVLEYYSSTSM | 486 | Q8N5R6 | |
| LADVYRTYDADMTTS | 391 | Q9NP70 | |
| YGLSEADMEASYATV | 106 | O00178 | |
| VEGDMYESANSRDEY | 636 | Q92793 | |
| GYRSEDPDTSMDSYA | 426 | P50416 | |
| NDGTTLAIASSYMYE | 286 | O43684 | |
| RYAEGTFISDYSIAM | 51 | P09681 | |
| NADSLMLVDFEYSSY | 256 | Q9Y259 | |
| ASMSTIEFGYLDYAQ | 361 | Q9Y259 | |
| GDTLVIASTDYSMYQ | 436 | Q8WUJ3 | |
| YLAAATTAVYEAMTA | 326 | P54802 | |
| FAYDSDVTGCASMYL | 266 | P43268 | |
| YQELESDGSTMEDYS | 221 | Q6P1R3 | |
| YASSAIAGMVAGSEY | 386 | Q06710 | |
| ILTVTATDADEGYYA | 261 | Q9Y5H1 | |
| DMSGYTIYDTSTDRL | 101 | Q96AZ6 | |
| ENVDMRDSYLGYSTE | 396 | P20702 | |
| SMYDLDGNGYISREE | 106 | P84074 | |
| MTDVETTYADFIASG | 1 | P61925 | |
| DTESFILAAMAYDRY | 111 | Q13606 | |
| LTISGTQAMDEADYY | 91 | P01715 | |
| LDYATGAIGSVYDMD | 931 | Q8TEW8 | |
| IGDFGMSRDIYSTDY | 666 | P04629 | |
| DSYTLAAMAYDRAVA | 111 | Q9Y585 | |
| TETDGDMLGYDLYSS | 431 | Q9ULH0 | |
| MDYDDSSSSYSSLGD | 626 | Q8WXG6 | |
| MATTEDAQAAVDYYT | 441 | P43243 | |
| NVYARGTDYDMDFTL | 106 | Q8IYB1 | |
| GVSNEMYTEYLSSAF | 596 | Q12791 | |
| LYQMEDEAYSSLAEA | 361 | Q8N9B5 | |
| YSMLGTYSDEFGNLD | 746 | Q9UJA3 | |
| EAYEDELDMGRSGSY | 681 | Q5T848 | |
| AAEMYGSSFDLDYNL | 101 | B7ZW38 | |
| LERYSEQMTYGISSE | 491 | O15111 | |
| MESTSLDDVLYRYAS | 86 | Q8NAA5 | |
| STSAESDMYYGQSLL | 1161 | Q2LD37 | |
| GYETTSSVLSFIMYE | 306 | P08684 | |
| DMADYSAALDPAYTT | 11 | P41235 | |
| YTSALTYDGVLVMAE | 296 | P48058 | |
| MSDGSYSPDYSLAAV | 481 | P54750 | |
| SMYDLDGNGYISRSE | 106 | P37235 | |
| TMKSAEEEHYGYASS | 36 | O95644 | |
| TGYTQEDYTMLGSDD | 411 | Q9P2S2 | |
| CEREATVLSYDGSMY | 726 | Q9P2S2 | |
| GYTQEDYTMLGSDDF | 366 | Q9Y4C0 | |
| TSTEAMTYDEASAYC | 26 | P16581 | |
| NYSVMDICDYDESSG | 321 | P27487 | |
| SVSDPKATMYSYDSA | 386 | P18505 | |
| QECMLDLESYGYSSE | 176 | O14764 | |
| AAEMYGSSFDLDYNL | 101 | P0DMR1 | |
| YYSSFVNMERDLASG | 551 | P00451 | |
| VMSLDYDSVSDRIYF | 2421 | P98164 | |
| TTTGYTQEDYTMLGS | 396 | Q9ULB1 | |
| AGYEIVLYISMSDSD | 196 | Q9Y2J8 | |
| GATEFYLLASMSYDR | 106 | Q8NGE1 | |
| DAQSGEDYDSFLMYS | 1336 | P16144 | |
| SMVSSATYGGSDDYI | 1411 | Q6R327 | |
| DSIYEASSLYGISAM | 201 | Q96EY5 | |
| TLAFVFDVTGSMYDD | 41 | Q96RW7 | |
| MYDVYIAAETSAGTG | 411 | Q9UMZ3 | |
| ASALFDMIEYYESAT | 151 | O75864 | |
| VDDTTEEQGYGMAYT | 421 | Q9H237 | |
| DMYSEVLDVLSDYDA | 266 | O60313 | |
| YSRYGSEEALSSTMG | 266 | Q86VX9 | |
| ALEEGNYFEMSTYST | 291 | P36888 | |
| YSSVYDSISMETLSD | 796 | B5ME19 | |
| VAMQDGDPTEYYSTA | 491 | Q8N9C0 | |
| DSYLLPTTDMYDNGS | 161 | Q8TE85 | |
| ASVGAEEYMYDQTSS | 231 | Q6ISB3 | |
| FMNYYAGVSASIDTD | 181 | Q8WWF8 | |
| AMYDDESAIDFSAYI | 51 | P49716 | |
| SAGDYVVMTIYFELS | 236 | Q99928 | |
| EFIAMYTYESSEQGD | 1006 | Q15811 | |
| DYAFSGMIRDSSYLS | 471 | Q5VZB9 | |
| DYGSESTSSMEDYVN | 16 | P51686 | |
| SGDYVVMSVYFDLSR | 256 | P18507 | |
| TATTYMEYETLTLGD | 186 | P53634 | |
| ASTDYSMYQAEEFTL | 436 | Q9UHN6 | |
| IGDFGMTRDVYETDY | 1131 | P14616 | |
| NAEMFGSTYCDYTIE | 226 | Q8NEG0 | |
| SMRVATGLYEAYEAE | 126 | Q9NQR7 | |
| MEDGFSSYSSLYDTS | 1 | O00423 | |
| SGADDTVYMEYHSSR | 751 | P19447 | |
| ELLRYYTSASGDEMV | 461 | P07900 | |
| YTSASGDEMVSLKDY | 466 | P07900 | |
| DSMYAEDSEGNNLSY | 251 | Q9H069 | |
| ATGFAYYSLAMGVEE | 336 | Q8TCC7 | |
| SSGSIDYDEYNIMKD | 816 | A6NMZ7 | |
| ASGTECYITSDMFYV | 96 | Q15648 | |
| EDVSREAGYDSTYGM | 1466 | Q9HC10 | |
| IDQSADSEGDYMSYQ | 1356 | Q7Z2Y5 | |
| YYSATILQMSGVEDD | 346 | Q96QE2 | |
| YLDMDSYPEAAAAAV | 161 | Q9BQG1 | |
| YYSSDPMDQVGDSTV | 421 | Q9NRR4 | |
| DSYGENYLSFTLTME | 1756 | Q92673 | |
| FRGEAAVTDSYSMDA | 96 | Q9NQ03 | |
| SDFGMARYVLDDQYT | 506 | P42680 | |
| EAYVEVAAYASMSIF | 311 | Q6P1X5 | |
| EYLYTGMFTSSPDLD | 556 | Q9BYZ6 | |
| QEDSGHDTMSYRDSY | 1156 | Q8TCU6 | |
| SYDAAGTIHDYVVAM | 171 | Q9UHJ6 | |
| AMESSSGEEYYVASD | 2356 | Q9NT68 | |
| YETEEGAHDLYMDTG | 131 | Q9Y535 | |
| AHSYTSVMVDGELYS | 161 | Q92854 | |
| SVMVDGELYSGTSYN | 166 | Q92854 | |
| DSDMNDAYLGYAAAI | 396 | P11215 | |
| TYYQGLFSTADLDSM | 236 | Q9H6W3 | |
| FASVMTDEYLYSGTA | 191 | O95025 | |
| LQYASTEVDGERYMT | 21 | O75746 | |
| DSYIKADDPSSYMEV | 1126 | Q00610 | |
| MYDSDSDGRITLEEY | 121 | Q96BS2 | |
| TVADSDESYMEKSLY | 106 | Q9HAW4 | |
| EASAFSYYGVMALTA | 706 | Q9H8M5 | |
| ERMVEDYLASGYQDS | 26 | Q8N587 | |
| HSVADGEMYRYSEDE | 591 | Q9UN79 | |
| GDTDMTDYVAYVAKD | 256 | P98077 | |
| SGDVYYNTGDVLAMD | 526 | Q9Y2P5 | |
| GLAYATEAVYESAEA | 461 | Q14247 | |
| MLNDSDDDVIYGSDY | 576 | Q9P2C4 | |
| AEMYDDVHSDGRYSL | 51 | Q8IX01 | |
| NELLMAISDSDYYTD | 131 | Q93063 | |
| MAGEITETGELYSSY | 1 | Q8NE00 | |
| EESAYYSDLFAMIGT | 201 | Q02094 | |
| SMVYSEEGAEDRTFA | 81 | Q14683 | |
| LYPDATEGEAYADMS | 1676 | Q709C8 | |
| ADYMASTIGFYSESG | 201 | Q9H920 | |
| VAVMSYSGYDIEDAL | 741 | Q9NW08 | |
| RVDFYEAMDDYTSAI | 71 | Q5I0X7 | |
| ISTDKAEYTFYEGMG | 331 | Q06330 | |
| YYASGSEFDEMFVGV | 401 | Q96TA2 | |
| MTRYVLDDEYVSSFG | 411 | P42681 | |
| IDMGYGYDESDSFID | 126 | Q9NPG3 | |
| TYVDHMDGSYSLSAL | 241 | Q92558 | |
| VIASDGYSYEKEAME | 421 | Q8N9V3 | |
| GDYDGDSQMDVLLTY | 106 | Q8TB96 | |
| AIVAVISYTGYDMED | 741 | Q9H9Y6 | |
| QMSEYDAATYERFSG | 1631 | A3KMH1 | |
| SAGYIYTQLMEEASS | 2066 | Q5T4S7 | |
| DYIEAESSYSRALEM | 131 | Q99614 | |
| AAAGMVFYSISDVTD | 916 | Q68DK2 | |
| MTDDSEYYVTAGDEK | 316 | Q00872 |